semaglutide for ckd Long-term kidney outcomes of in obesity and cardiovascular disease in the SELECT trial semaglutide and kidney disease FLOW

Health 12 BowmanM

Despite it being rare, patients and doctors should be acutely aware of the side effects involved. As a clinician, how should I manage medication-induced gastroparesis

Researchers found that GLP-1 agonists used for weight loss were associated with increased risks of pancreatitis, gastroparesis, and bowel obstruction compared with bupropion-naltrexone, although that study should be understood as observational rather than definitive proof of causation

PlexusDx's semaglutide is $189/mo month-to-month, or from $149/mo on the 6-month plan, compared to $900+ for brand Ozempic

Pharmaceutical litigation is expensive